Skip to Main Content

Paper Details

Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer: Critical Analysis of Strengths, Weaknesses, and Misinterpretations.
JAMA Oncol
17
2022
BC, Early Breast Cancer, breast cancer, circulating tumor, ctDNA, pCR, patient, patients
Author NameAffiliation
Gabriel N HortobagyiThe University of Texas MD Anderson Cancer Center
Eric P WinerYale Cancer Center
Antonio C WolffJohns Hopkins University
  • 1 - 3

Datasets